Novonix (NVX) EPS (Weighted Average and Diluted) (2022 - 2024)

Novonix has reported EPS (Weighted Average and Diluted) for 3 years, with the latest figure at -$0.0 in Q4 2024.

• For the quarter ending Q4 2024, EPS (Weighted Average and Diluted) changed 0.25% year-over-year to -$0.0; the trailing twelve-month figure through Dec 2024 stood at -$0.0 (changed 0.25% YoY), and the FY2025 full-year result was -$0.14, up 6.67% from the prior year.
• EPS (Weighted Average and Diluted) for Q4 2024 stood at -$0.0, roughly flat from -$0.0 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was -$0.0 in Q4 2023, with the low at -$0.09 in Q2 2022.
• Historically, EPS (Weighted Average and Diluted) has averaged -$0.03 across 3 years, with a median of -$0.0 in 2024.
• The largest YoY upside for EPS (Weighted Average and Diluted) was 0.25% in 2024 against a maximum downside of 0.25% in 2024.
• Novonix's EPS (Weighted Average and Diluted) stood at -$0.09 in 2022, then jumped by 99.94% to -$0.0 in 2023, then fell by 0.25% to -$0.0 in 2024.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.0 (Q4 2024), -$0.0 (Q4 2023), and -$0.09 (Q2 2022), per Business Quant data.